| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | Director | Common Stock | 39.4K | $131K | $3.32 | Jun 30, 2023 | Direct |
| Cyclacel Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 42.4K | Jun 30, 2023 | Direct | ||
| PROTHENA CORP PUBLIC LTD CO | Director | Ordinary Shares, par value $0.01 per share | 0 | $34.00 | Jul 14, 2021 | Direct | |
| PROTHENA CORP PUBLIC LTD CO | Director | Stock Option (Right to Buy) | 0 | Jul 14, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 30, 2023 | 2 | $0 | 4 | Jul 3, 2023 | Director |
| CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Jul 14, 2021 | 4 | -$490K | 4 | Jul 16, 2021 | Director |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Jul 12, 2021 | 17 | -$1.09M | 4/A | Jul 13, 2021 | Director |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Jun 25, 2021 | 4 | -$376K | 4 | Jun 29, 2021 | Director |
| CYCC | Cyclacel Pharmaceuticals, Inc. | Jun 15, 2021 | 2 | $0 | 4 | Jun 17, 2021 | Director |
| PRTA | PROTHENA CORP PUBLIC LTD CO | May 19, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |